WOLVERINE TRADING, LLC - HERON THERAPEUTICS INC ownership

HERON THERAPEUTICS INC's ticker is HRTX and the CUSIP is 427746102. A total of 191 filers reported holding HERON THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is 0.29 and the average weighting 0.1%.

Quarter-by-quarter ownership
WOLVERINE TRADING, LLC ownership history of HERON THERAPEUTICS INC
ValueSharesWeighting
Q2 2022$38,000
-88.8%
12,100
-79.7%
0.00%
Q1 2022$339,000
+235.6%
59,600
+446.8%
0.00%
Q4 2021$101,000
-76.8%
10,900
-60.9%
0.00%
Q2 2021$436,000
-58.9%
27,900
-59.8%
0.00%
-100.0%
Q1 2021$1,061,000
+102.5%
69,328
+181.8%
0.00%
Q4 2020$524,000
-57.7%
24,600
-71.7%
0.00%
-100.0%
Q2 2020$1,240,000
+8.8%
86,994
-10.8%
0.00%0.0%
Q1 2020$1,140,000
-53.7%
97,500
-6.4%
0.00%
-33.3%
Q4 2019$2,460,000
+64.8%
104,127
+36.7%
0.01%
+20.0%
Q3 2019$1,493,000
-53.3%
76,177
-55.7%
0.01%
-44.4%
Q2 2019$3,200,000
+19.1%
172,120
+56.6%
0.01%
+28.6%
Q1 2019$2,686,000
+3.9%
109,927
+1.0%
0.01%0.0%
Q4 2018$2,584,000
-21.0%
108,810
+5.3%
0.01%0.0%
Q3 2018$3,269,000
-30.1%
103,314
-39.0%
0.01%
-36.4%
Q2 2018$4,677,0000.0%169,4500.0%0.01%0.0%
Q1 2018$4,677,000
+370.5%
169,450
+208.7%
0.01%
+266.7%
Q4 2017$994,000
+82.7%
54,900
+62.9%
0.00%
+50.0%
Q3 2017$544,000
+103.0%
33,700
+74.6%
0.00%
+100.0%
Q2 2017$268,000
-34.0%
19,300
-27.4%
0.00%
-50.0%
Q1 2017$406,000
+61.8%
26,600
+81.0%
0.00%
+100.0%
Q3 2016$251,00014,7000.00%
Other shareholders
HERON THERAPEUTICS INC shareholders Q1 2022
NameSharesValueWeighting ↓
TANG KEVIN C 21,288$250,00019.87%
TANG CAPITAL MANAGEMENT LLC 2,896,904$34,010,0004.78%
PFM Health Sciences, LP 2,481,917$29,138,0002.39%
Iron Triangle Partners LP 500,000$5,870,0002.27%
NEXPOINT ASSET MANAGEMENT, L.P. 777,599$9,129,0001.72%
Pekin Hardy Strauss, Inc. 588,732$6,912,0001.55%
First Light Asset Management, LLC 691,400$8,117,0001.39%
Congress Park Capital LLC 111,045$1,304,0001.18%
Mesirow Financial Investment Management, Inc. 15,135$178,0001.12%
Elk Creek Partners, LLC 509,174$5,978,0001.03%
View complete list of HERON THERAPEUTICS INC shareholders